Providing high-quality medical care for individuals with cancer during their last year of life involves a range of challenges. An important component of high-quality care during this critical period is ensuring optimal patient satisfaction. The objective of the current study was to assess factors influencing health care ratings among individuals with cancer within 1 year before death. METH-ODS: The current study used the Surveillance, Epidemiology, and End Results (SEER)-Consumer Assessment of Healthcare Providers and Systems (CAHPS) data set, a new data resource linking patient-reported information from the CAHPS Medicare Survey with clinical information from the National Cancer Institute's SEER program. The study included 5102 Medicare beneficiaries diagnosed with cancer who completed CAHPS between 1998 and 2011 within 1 year before their death. Multivariable logistic regression analyses examined associations between patient demographic and insurance characteristics with 9 measures of health care experience. RESULTS: Patients with higher general or mental health status were significantly more likely to indicate excellent experience with nearly all measures examined. Sex, race/ethnicity, and education also were found to be significant predictors for certain ratings. Greater time before death predicted an increased likelihood of higher ratings for health plan and specialist physician. Clinical characteristics were found to have few significant associations with experience of care. Individuals in fee-for-service Medicare plans (vs Medicare Advantage) had a greater likelihood of excellent experience with health plans, getting care quickly, and getting needed care. CONCLUSIONS: Among patients with cancer within 1 year before death, experience with health plans, physicians, and medical care were found to be associated with sociodemographic, insurance, and clinical characteristics. These findings provide guidance for the development of programs to improve the experience of care among individuals with cancer. Cancer 2017;123:336-44.
INTRODUCTION
Cancer is a leading cause of death in the United States, with 589,430 individuals projected to have died of cancer in the United States in 2015. 1 During the last year of life, individuals with cancer may experience debilitating physical symptoms and psychological distress, 2 and may receive a broad range of medical care services. [3] [4] [5] [6] Providing high-quality medical care for individuals with cancer during their last year of life involves multiple challenges. [7] [8] [9] An important component of high-quality cancer care is ensuring optimal patient satisfaction. Satisfaction can influence a variety of behaviors and outcomes, 10 and is related to quality of care and quality of life among individuals shortly before death. 11 Only a few studies to date have examined satisfaction with health care among individuals with cancer in their last year of life. [12] [13] [14] These studies may include mixed populations, including individuals with cancer and other serious medical conditions, and generally have samples that cannot provide detailed assessments of the factors influencing a patient's experience with health care in the last year of life.
The Surveillance, Epidemiology, and End Results (SEER)-Consumer Assessment of Healthcare Providers and Systems (CAHPS) data set is a recently developed data resource linking patient-reported information from the CAHPS Medicare Survey with clinical information from the National Cancer Institute's SEER program. 15 To our knowledge, this is the first data set to permit examination of clinical characteristics and experiences of care among large US populations of individuals diagnosed with cancer. The objective of the current study was to describe patient experience with physicians, health plans, and medical care and assess associations between patient characteristics and these experiences among individuals with cancer who completed the survey within 1 year before their death.
MATERIALS AND METHODS
The SEER-CAHPS data set contains information from Medicare beneficiaries who responded to the CAHPS survey and were diagnosed with cancer while residing in SEER regions. 15 For the current study, data included surveys collected between 2000 and 2011 for 160,959 Medicare beneficiaries. Eligibility criteria included: 1) the first cancer diagnosis in SEER was either the only or a first primary tumor; 2) beneficiaries were aged 66 years at the time of survey completion; 3) the CAHPS survey was completed after the cancer diagnosis; and 4) beneficiaries died within 12 months of completing the survey. For the minority of beneficiaries who completed multiple surveys, the most recent survey was analyzed. The study sample included 4689 Medicare beneficiaries who had cancer and were within 1 year before their death at the time of survey completion.
The CAHPS survey included 4 single-item measures assessing patient experience with overall care, health plan, primary physician, and specialist physician. Each measure was rated on a scale of 0 to 10, with 0 representing the lowest patient rating and 10 representing the highest. CAHPS survey responses also were used to generate 5 composite measures: 1) customer service; 2) physician communication; 3) getting care quickly; 4) getting needed care; and 5) getting needed prescription drugs. Similar to previous CAHPS analyses, 16 because ratings on single items and composite items were negatively skewed with the majority of responses at the extreme upper end of the scales, we classified ratings as being "excellent" for singleitem measures (scored on a scale of 0-10) if responses were 9 or 10. Similarly, for composite measures (scored on a scale of 0-100), we classified experience reports as "excellent" for scores of 100. There were substantial ceiling effects for composite scores; few respondents provided scores that were >90 but < 100. Details regarding these measures have been presented elsewhere. 17, 18 Additional information on the Medicare CAHPS survey is available at https://cahps.ahrq.gov/surveys-guidance/hp/about/ Medicares-CAHPS-HP-Survey.html. With regard to the selection and construction of model variables, careful attention to slight changes in and ordering of items in the CAHPS surveys over time was required.
For the single-item measures, nonvalid missing values ranged from approximately 6% for rating of health plans to 10% for rating of specialists. Comparisons of individual characteristics for patients with nonmissing versus nonvalid missing responses for each of the 4 singleitem measures are presented in Supporting Information Table 1 . Although the characteristics of individuals with missing single-item measures varied among the measures, significant differences were observed between populations with missing versus nonmissing responses for all measures by education, general health status (GHS), and mental health status (MHS). For composite measures, all missing values were considered valid CAHPS responses (eg, responses of "don't know" or nonresponses due to skip patterns or question exclusion).
Associations between patient sociodemographic characteristics and excellent ratings were examined using multivariable logistic regression analyses, with separate regressions models for each of the 4 single-item and 5 composite measures. Dependent variables were dichotomous excellent/not excellent ratings for each measure. Sociodemographic independent variables (with reference categories listed first) were sex (female/male), race/ethnicity (non-Hispanic white, non-Hispanic black, nonHispanic Asian, Hispanic, or other), education (<high school, high school, some college, college graduate, or missing data), Medicare plan type (managed care vs feefor service [FFS] ), age at time of the completion of the CAHPS survey (66-74 years, 75-79 years, 80-84 years, or 85 years), years from first cancer diagnosis to survey (>5 years, 2-5 years, or < 2 years), months from survey to death (0-3 months, 4-7 months, or 8-12 months), and assistance in completing the survey (no, yes, or missing data). Months from survey completion to death were based on exact survey completion dates for 2007 through 2011 respondents and approximate dates for 2000 through 2006 respondents; supplemental multivariable regression analyses (data not shown) indicated nonsignificant interactions between months from survey completion to death and year of survey completion, suggesting no differential effect of year of survey completion for this variable. Because there were few significant associations with study outcomes noted for age group, years from diagnosis to survey, months from survey completion to death, or assistance in completing the survey, analysis results for these variables are presented in Supporting Information Tables 2 and 3 .
Clinical independent variables included type of cancer, number of primary cancers at the time of diagnosis (single vs multiple), stage of cancer at the time of diagnosis (in situ/local, regional, distant, unknown/unstaged, or missing data), cause of death (cancer vs all other causes), single versus multiple primary tumors at the time of diagnosis, and self-reported GHS and MHS coded on a 5-point scale (poor, fair, good, very good, or excellent). Type of cancer was categorized as 1 of the 4 most common types in the United States (breast, colorectal, lung, or prostate) or "other," which included all other cancer types in the study population. In regression analyses, excellent and very good health statuses were combined due to infrequent excellent ratings for GHS. In addition, the state in which the SEER registry was located at the time of the first cancer diagnosis and survey year (2000-2011) were included as independent variables.
Statistical Analysis
All analyses were performed using SAS statistical software (version 9.4; SAS Institute Inc, Cary NC). Statistical significance was assessed at P<.05. No weighting of the study sample was performed in analyses. Table 1 presents characteristics of the study population by cancer type. Among the 4689 patients meeting the study inclusion criteria, 54.5% were male. The majority of patients in all groups were non-Hispanic white (78%-85%); patients with prostate cancer included the largest percentages of non-Hispanic black (9%) and Asian (4%) patients, whereas patients with cancer of other sites included the largest percentage of Hispanic individuals (6%). As presented in previous studies using SEER data, a substantial percentage of patients were missing data regarding stage of disease at the time of diagnosis. Among those with nonmissing stage of disease data, patients with lung cancer were more likely to be diagnosed with a distant stage of disease. Patients with lung cancer also were most likely to die of cancer, whereas patients with cancers of the breast and prostate were found to be the least likely to die of cancer. Table 1 also presents percentages of patients by cancer type who provided excellent ratings for the 4 singleitem and 5 composite item survey measures. The percentages of patients providing excellent responses were similar across the cancer groups; the largest difference was for customer service, with approximately 43% of patients with breast cancer versus 55% of patients with lung cancer indicating excellent customer service. There were more pronounced differences noted across the categories, with the highest percentages of patients providing excellent ratings for the primary physician, specialist physician, and getting needed prescription drugs measures, and the lowest percentages for the customer service and physician communication measures. Table 2 presents results from multivariable logistic regression analyses examining the association between patient characteristics and the provision of excellent ratings for the single survey items. Odds ratios (ORs) as presented in Tables 2 and 3 were determined controlling for all variables listed in these tables as well as GHS, MHS, age group, years from diagnosis to survey, months from survey to death, assistance with survey completion, the state in which the SEER registry was located at the time of the first cancer diagnosis, year of CAHPS survey, and presence of multiple cancers. Males were found to be significantly less likely to provide excellent ratings for health plans or specialist physician compared with females. College graduates were found to be significantly less likely to provide excellent ratings for overall care or health plans, whereas Hispanic patients were more likely to provide excellent ratings for health plan or specialist physician compared with non-Hispanic white individuals. Having FFS was found to be significantly associated with a greater likelihood of excellent ratings for health plan. Table 3 presents associations between patient characteristics and excellent experience for composite survey measures. Similar to the results in Table 2 , men and college graduates were found to be significantly less likely to report excellent experience for several measures. Asian and Hispanic patients also were found to be significantly less likely to indicate excellent experience for getting needed care and Asian patients also were less likely to report excellent experience for getting needed prescription drugs. Both patients with breast cancer and those with lung cancer were found to be more likely to report excellent experience for getting care quickly. Patients with FFS Medicare coverage (vs Medicare Advantage) were more likely to report excellent experience for getting care quickly, getting needed care, and getting needed prescription drugs.
RESULTS
Figures 1 and 2 present ORs for associations between patient-reported GHS and MHS and excellent ratings for single-item and composite item measures. Very good/excellent (vs poor) GHS (Figure 1 ) was associated with significantly greater likelihood of reporting excellent ratings for all single-item measures and all composite item measures except customer service (P 5 .063). Having fair or good GHS also was found to be associated with excellent experience with physician communication, whereas fair GHS also was found to be associated with excellent experience with customer service.
In Figure 2 , having very good/excellent (vs poor) MHS was associated with significantly greater likelihood of Original Article excellent ratings for all single-item measures and all composite item measures except getting needed prescription drugs. Good MHS was associated with excellent ratings for primary physician (P 5 .0499), whereas fair or good MHS was associated with excellent ratings for health plans.
DISCUSSION
The current study is the first to use SEER-CAHPS data to examine associations between experience of health plans, physicians, and medical care and characteristics of Medicare beneficiaries with cancer during their last year of life. SEER-CAHPS is a unique resource, permitting the examination of patient characteristics and experiences of care among a large US population of individuals diagnosed with cancer. More broadly, to our knowledge the current study is the first to assess factors influencing health care experience among individuals with cancer during their last year of life. The majority of prior research concerning preferences among individuals with cancer in their last year of life has focused on the preferred place for end-oflife care 19 and the level of involvement in treatment decisions 20 rather than issues associated with health plans, physicians, and access to care.
We found that primary and specialist physicians had the greatest percentage of "excellent" ratings whereas physician communication had among the lowest percentage. The contrast suggests that patients rate their physicians using factors other than quality of communication.
The findings of the current study indicate that men and college graduates were less likely to provide high ratings for health plans and other aspects of medical care. Hispanic patients were more likely to indicate excellent experience with health plans or specialist physician but less likely to do so for getting needed care. Asian patients were less likely to indicate excellent experience with specialist physician, getting needed care, and getting needed prescription drugs. Similar to the findings presented here, Ayanian et al 21 reported that college graduates with colorectal cancer experienced increased problems with cancer care compared with high school graduates. These researchers also found that Asian/Pacific Islander and Hispanic patients were less likely to rate their overall cancer care as very good or excellent compared with white patients, whereas we found mixed ratings among Hispanic patients.
Patients with lung cancer were more likely to indicate excellent experience with primary physicians and getting care quickly, whereas individuals diagnosed with distant disease were more likely to indicate excellent experience with specialist physician and customer service. These 2 groups overlap (ie, individuals with lung cancer were more likely to be diagnosed with advanced stage disease), and may be more attuned to their medical care due to the more serious nature of their disease. Similarly, those patients who died of cancer, who were also more likely to have advanced disease, were significantly more likely to provide excellent ratings for their overall care. Individuals with FFS Medicare coverage were found to have a greater likelihood of indicating excellent experience with health plans, getting care quickly, getting needed care, and getting needed prescription drugs. Previous studies comparing Medicare FFS with managed care have been mixed. Some have reported improved quality among patients with FFS coverage 22 whereas others have reported that patients with managed care plans are more likely to receive preventive care services. 23, 24 The results of the current study suggest that for patients with cancer who are in their last year of life, the experience of care in FFS Medicare is superior to that in Medicare Advantage.
The strongest and most consistent associations between patient characteristics and experience of care were observed for health status (Figs. 1 and 2) . Patients with very good/excellent GHS or MHS, which suggests fewer symptoms in the year preceding death, were significantly more likely to indicate excellent experience for nearly all measures examined. This indicates that improving GHS and MHS among patients with cancer in the last year of life may improve experiences with care. Increasing early access to palliative/supportive care services may help to improve health status. Palliative care can improve outcomes for individuals with cancer, 25, 26 and earlier initiation of palliative care can result in greater improvements in physical/mental health, quality of life, and satisfaction. [27] [28] [29] Recent recommendations have advocated earlier integration of palliative care into oncology care. 30, 31 The analyses in the current study are particularly relevant to recent decisions from the Centers for Medicare and Medicaid Services providing physician payments for end-of-life counseling. 32 Because these results indicate substantial differences by patient characteristics in experiences with care during the last year of life, individualized patient counseling may help to identify differences in patient preferences, address unmet needs, and improve quality of care during this critical period. Patients with cancer who discuss preferences for end-of-life care with physicians are more likely to receive care consistent with these preferences. 33 Results from this study may help to provide a framework for end-of-life discussions, identifying strategies for improving care.
There are limitations to the current study, largely related to the data used. We were unable to examine changes in patient experience over time or verify whether this experience remained constant. Furthermore, it was not possible to validate the CAHPS responses; there is no "gold standard" with which these responses can be compared. Similarly, GHS and MHS are based on self-report and therefore could not be validated. However, CAHPS surveys have been widely used for nearly 20 years to assess patient-reported perceptions of care and associations between patient demographic, clinical, and insurancerelated factors with experience of care. 15 As such, these measures represent well-accepted standards for assessing patient experience of care. An additional limitation is that although patient responses were from the last year of life, the "last year of life" can only be determined retrospectively. Individuals who were diagnosed with a poor-prognosis cancer or with a cancer at a distant stage may have had <1 year of survival after diagnosis. The estimated duration of survival is highly uncertain for many individuals with cancer. Although our analyses controlled for time from diagnosis to survey and from survey completion to death (which, combined, is the duration of survival after diagnosis), uncertainties in life expectancy may have affected patients' ratings.
The results of the current study provide important information regarding experiences of care for patients with cancer in their last year of life using a new resource, the SEER-CAHPS data set. Among these individuals, experience with health plans, physicians, and aspects of medical care are associated with sociodemographic, insurance, and clinical characteristics. These findings provide guidance for the development of programs to improve experience with medical care among individuals who are anticipated to be in their last year of life. It will be important to explore aspects of FFS Medicare that are associated with an enhanced experience of care. Subsequent research also may examine programs addressing potentially modifiable patient factors, in particular GHS and MHS, on patient experience with care during this critical time period.
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